India wants Pfizer to do local study for Covid-19 vaccine approval

NEW DELHI : Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its Covid-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters. Serum Institute of India, the local manufacturer of the vaccine...